Abstract Background and aims Stroke is a leading global cause of death and disability, with post-stroke cognitive impairment (PSCI) as its most common complication. Our prior single-cell sequencing of stroke patient brains revealed significant upregulation of the aryl hydrocarbon receptor (Ahr), which correlated with cognitive outcomes. Although Ahr is known to function in microglia, its role in stroke and PSCI remains unclear. Methods We constructed Ahr+/+ and Ahr-/- transgenic mice and induced ischemic stroke via the dMCAO model. Cognitive behavior, infarct volume (TTC staining), and histopathology were assessed. A microglia-neuron co-culture model under oxygen-glucose deprivation (OGD) was used to examine the effect of microglial Ahr on neuronal morphology and synaptic spines. Transcriptomic analysis of Ahr-modulated microglia identified synaptic regulatory pathways, which were validated in vivo and in vitro. Results Ahr-/- mice showed larger cerebral infarcts and significant cognitive decline at 24 weeks post-stroke, whereas Ahr+/+ mice had smaller infarcts and improved cognitive function. Inhibiting Ahr in microglia alleviated OGD-induced synaptic spine loss and neuronal damage. Transcriptomics revealed Ahr-associated synaptic pathways in microglia. Conclusions Ahr in microglia improves infarct size and cognitive recovery after stroke by regulating synaptic function, highlighting its protective role in PSCI. Conflict of interest Name of author: nothing to disclose
Building similarity graph...
Analyzing shared references across papers
Loading...
Can Cui
Gang Li
European Stroke Journal
Shanghai East Hospital
Building similarity graph...
Analyzing shared references across papers
Loading...
Cui et al. (Fri,) studied this question.
www.synapsesocial.com/papers/69fd7e23bfa21ec5bbf0652d — DOI: https://doi.org/10.1093/esj/aakag023.1429